Apyx Medical (APYX) Enterprise Value (2010 - 2026)

Apyx Medical has reported Enterprise Value for 17 years, with the latest figure at -$30.9 million in Q1 2026.

• For the quarter ending Q1 2026, Enterprise Value changed 0.01% year-over-year to -$30.9 million; the trailing twelve-month figure through Mar 2026 stood at -$30.9 million (changed 0.01% YoY), and the FY2025 full-year result was -$31.4 million, up 0.53% from the prior year.
• Enterprise Value for Q1 2026 stood at -$30.9 million, up from -$31.4 million in the prior quarter.
• The five-year high for Enterprise Value was -$10.0 million in Q4 2022, with the low at -$43.4 million in Q4 2023.
• Historically, Enterprise Value has averaged -$26.3 million across 5 years, with a median of -$27.9 million in 2024.
• Annual changes were most pronounced in 2022 — Enterprise Value soared 67.36% — and 2023, when it plunged 335.49%.
• Apyx Medical's Enterprise Value stood at -$10.0 million in 2022, then sank by 335.49% to -$43.4 million in 2023, then increased by 27.2% to -$31.6 million in 2024, then climbed by 0.53% to -$31.4 million in 2025, then gained by 1.81% to -$30.9 million in 2026.
• The last three Enterprise Value figures came in at -$30.9 million (Q1 2026), -$31.4 million (Q4 2025), and -$24.9 million (Q3 2025), per Business Quant data.